PATENT CLAIM ANALYSIS

Application Number: 16031418
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "141100"]

Abstract:
The present invention is directed to an anti-prion monoclonal antibody and its use for the treatment of conditions associated with or mediated by proteins or peptides having a toxic oligomeric form. These conditions include, but are not limited to, Alzheimer's disease, frontotemporal dementias, traumatic brain injury, and chronic traumatic encephalopathy.

Claim (Index 16):
The antibody or binding fragment thereof of  claim 1 , wherein said antibody or binding fragment thereof is selected from the group consisting of: a disulfide linked Fv, a scFv, a CDR-grafted antibody, a diabody, a multispecific antibody, a Fab, a Fab\u2032, a bispecific antibody, a F(ab\u2032) 2 , and a Fv.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 95.0
- Lexical Diversity: 1.20833
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13773264', '12999045', '14616300', '15324141', '14407724']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7557371170837645
- 35 USC 102 Novelty (BERT): 0.537388924901924
- Combined Prediction Score: 0.7339022978655804
- Mean Citation Score: 357.33605400000016
- Max Citation Score: 366.13882
- Similarity Product: 285.94674315621137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test